Catalyst Wire Dossier Catalyst Wire Dossier

Celsunax

ioflupane (123I) · Pinax Pharma GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Celsunax, covering 2024-11-15 to 2024-11-15. Get the full timeline:

Most recent: EMA Authorised: Celsunax (ioflupane (123i)) — Pinax Pharma GmbH

See pricing